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Key points
 The presynaptic protein α-synuclein forms aggregates during Parkinson’s disease.
 Accumulating evidence suggests that the small soluble oligomers of α-synuclein are more toxic
than the larger aggregates appearing later in the disease.
 The link between oligomer toxicity and structure still remains unclear.
 In the present study, we have produced two structurally-defined oligomers that have a similar
morphology but differ in secondary structure.
 These oligomers were introduced into neocortical pyramidal cells during whole-cell recording
and, using a combination of experimentation and modelling, electrophysiological parameters
were extracted.
 Both oligomeric species had similar effects on neuronal properties reducing input resistance,
time constant and increasing capacitance. The net effect was a marked reduction in neuronal
excitability that could impact on network activity.
Abstract The presynaptic proteinα-synuclein (αSyn) aggregates during Parkinson’s disease (PD)
to form large proteinaceous amyloid plaques, the spread of which throughout the brain clinically
defines the severity of the disease. During early stages of aggregation, αSyn forms soluble annular
oligomers that show greater toxicity than much larger fibrils. These oligomers produce toxicity
via a number of possible mechanisms, including the production of pore-forming complexes that
permeabilizemembranes. In the present study, twowell-defined species of solubleαSyn oligomers
were produced by different protocols: by polymerization ofmonomer and by sonication of fibrils.
The two oligomeric species produced were morphologically similar, with both having an annular
structure and consisting of approximately the same number of monomer subunits, although they
differed in their secondary structure. Oligomeric and monomeric αSyn were injected directly
into the soma of pyramidal neurons in mouse neocortical brain slices during whole-cell patch
clamp recording. Using a combined experimental and modelling approach, neuronal parameters
were extracted to measure, for the first time in the neocortex, specific changes in neuronal
electrophysiology. Both species of oligomer had similar effects: (i) a significant reduction in input
resistance and the membrane time constant and (ii) an increase in the current required to trigger
an action potential with a resultant reduction in the firing rate. Differences in oligomer secondary
structure appeared to produce only subtle differences in the activity of the oligomers. Monomeric
αSyn had no effect on neuronal parameters, even at high concentrations. The oligomer-induced
fall in neuronal excitability has the potential to impact both network activity and cognitive
processing.
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Introduction
α-Synuclein (αSyn), a 14 kDa protein found abundantly
throughout the brain (Vivacqua et al. 2011), was one
of the first proteins to be pathologically associated with
Parkinson’s disease (PD). This association came initially
from identifying αSyn in the Lewy bodies of PD patients.
Indeed, the detection of these αSyn-containing plaques,
in various brain regions, remains a clinical hallmark for
classifying the progression of several neurodegenerative
disorders that are collectively termed synucleinopathies.
In some cases of familial PD, point mutations in αSyn
(A53T, A30P, E46K, H50Q and G51D) (Polymeropoulos
et al. 1997; Kruger et al. 1998; Zarranz et al. 2004; Lesage
et al. 2013; Proukakis et al. 2013) and genemultiplications
(Fuchs et al. 2007) promote the early onset of symptoms
as a result of an increase in the propensity of αSyn
to aggregate. However, increasing evidence suggests that
soluble, ring-likeoligomers aremoreneurotoxic andbetter
correlate with PD pathology than the larger insoluble
aggregates into which they form (Haass & Selkoe, 2007;
Winner et al. 2011).
NativeαSyn exists predominantly in the cytosol as either
an unfoldedmonomer (Fauvet et al. 2012) or as a helically
folded tetramer (Bartels et al. 2011; Wang et al. 2011a).
There have been many studies investigating the structure
and activity of αSyn oligomers, with oligomerization
protocols varying considerably with respect to the protein
concentration (Volles et al. 2001; Danzer et al. 2007),
incubation conditions (Lashuel et al. 2002; Lorenzen et al.
2014), buffer content (Hoyer et al. 2002) and the use of
inducers such as metal ions (Binolfi et al. 2006; Brown,
2009) or dopamine (Cappai et al. 2005). Unsurprisingly,
the oligomers produced with these different conditions
show variability in terms of their size, structure and
toxicity. Clearly, data on the biological activity of the
oligomers become difficult to interpret if the structure
is not defined.
Both in vitro and in vivo studies describe the
ability of αSyn oligomers to form membrane inserting
pore-complexes that can induce cell death through various
mechanisms, including membrane permeabilization
(Volles & Lansbury, 2002; Tosatto et al. 2012), Ca2+ influx
(Danzer et al. 2007), synaptic alterations (Diogenes et al.
2012; Pacheco et al. 2015) and mitochondrial dysfunction
(Guardia-Laguarta et al. 2014). Step changes inmembrane
conductance have been observed after incubating αSyn
with either planar bilayers (Kim et al. 2009; Schmidt
et al. 2012; Tosatto et al. 2012) or cell cultures (Feng
et al. 2010; Mironov, 2015). Many of these investigations,
however, attribute the observed electrophysiological
changes to oligomers that have not been structurally
characterized.
In addition to motor dysfunction, clinically diagnosed
PDpatients exhibit awide range of debilitating non-motor
symptoms that have a devastating impact on quality
of life (Chaudhuri et al. 2006). More than 80% of
Parkinson’s patients develop PD dementia, which can
include sleep disorders arising from αSyn aggregation
in the basal forebrain (Boeve, 2013), as well as neuro-
psychiatric symptoms, including depression, dementia,
hallucinations and emotional disturbances (Chaudhuri
et al. 2006), as a result of deposition in the deep layers
of the neocortex (Magen et al. 2012; Mu¨ller & Bohnen,
2013). However, compared to other areas involved in
cognitive function, little research has been carried out
investigating the impact of αSyn oligomers on neocortical
neurons.
In the present study, we provide the structural
characterization of two soluble oligomeric species of αSyn
and then inject these oligomers directly into thick-tufted
layer 5 (TTL5) pyramidal neurons in neocortical slices.
We decided to study this cell type, rather than SNC
dopaminergic neurons, because it is affected in late stage
PD (Braak et al. 2003) and we can employ an efficient
method for neuronal model identification (Badel et al.
2008). Subsequently, we can produce an in-depth analysis
of toxicity-induced changes in neuronal parameters giving
insight into the mechanism of oligomer activity. Over
time, neurons injected with these two oligomeric species
displayed a similar reduction in input resistance and
membrane time constant compared to either control or
monomer-injected neurons. Consequentially, the amount
of current needed for spike initiation was elevated
significantly. As expected, the firing rate was also
reduced, although this effect took longer to develop,
suggesting that it is not just a consequence of the fall in
input resistance. These effects on neuron excitability are
important because they could potentially change network
dynamics.
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Methods
Expression and purification of recombinant
αSynE46K,Y39W
The pGS-21a vector (GenScript Corporation, Piscataway,
NJ, USA) containing recombinant human αSyn with
two point mutations, E46K and Y39W, was trans-
formed into BL21∗ Rosetta Escherichia coli cells by heat
shock and then expression was induced with 1 mM iso-
propyl D-thiogalactopyranoside. Cells were harvested after
4 h of expression and resuspended in cold lysis buffer
(10 mM Tris, 1 mM EDTA, 1 mM phenylmethylsulphonyl
fluoride, pH 8.0). Cells were lysed by probe sonication
(3 × 30 s at 60 % power) and centrifuged (10,000 g
for 15 min at 4°C) to remove debris. The supernatant
was boiled for 10 min and re-centrifuged (20,000 g for
20 min at 4°C). Proteins, including αSyn, were removed
from the heat treated supernatant by ammonium sulphate
precipitation (50% saturation). The precipitated protein
was resuspended in Tris buffer (10 mM Tris/HCl, pH 8.0)
and re-solubilized overnight by dialysis using SnakeSkin
Dialysis Tubing (Thermo Scientific, Waltham, MA, USA).
The αSyn-containing sample was loaded onto a 10 ml
Source 30Q anion exchange column (GEHealthcare, Little
Chalfont, UK) equilibrated with Tris buffer at a flow
rate of 2 ml min−1. Proteins were eluted with a linear
NaCl gradient (0–700 mM; 2 ml min−1). The fractions
containing αSyn were collected between 280–340 mM
NaCl, concentrated by lyophilization and loaded onto
a HiPrep 26/60 Sephacryl S-300 High Resolution gel
filtration column (Amersham Biosciences, Piscataway,
NJ, USA). Fractions containing αSyn were determined
by SDS-PAGE and western blotting. Purified αSyn was
dialysed into 10 mM sodium phosphate buffer (pH 7.4),
aliquoted into 200 μl volumes, flash-frozen in liquid
nitrogen and stored at −20°C until use.
Oligomerization of αSyn
Oligomeric species ofαSynwere generatedby twodifferent
methods. The first method was modified from a protocol
described previously (Lorenzen et al. 2014). In brief,
lyophilized samples of monomeric αSyn were suspended
in 300–400μl of phosphate-buffered saline (PBS) (inmM:
137NaCl, 2.7 KCl, 8.1Na2HPO4 and 1.5 KH2PO4; pH 7.4)
+ 0.01% NaN3 to give a final concentration of between
10–12 mg ml−1. Samples were incubated at 37°C with
shaking (900 rpm) for 3 h in an Eppendorf Thermomixer
Compact (Fisher Scientific Co., Pittsburgh, PA, USA).
Insoluble aggregates were removed by ultracentrifugation
at 100,000 g (10 min at 4°C) and the supernatant
(containing soluble oligomer and monomer) was loaded
onto a Superdex 200 gel filtration column (GEHealthcare)
equilibrated with PBS, at a flow rate of 0.5 ml min−1.
The oligomer-containing fractions were collected and
concentrated using Amicon Ultra 0.5 ml centrifugal
filters (molecular weight cut-off 3 kDa) (Sigma-Aldrich,
St Louis, MO, USA). These oligomers, which were
produced directly from monomeric αSyn, are termed
mOligomers.
The second method produced oligomers by
fragmentation of large fibrillar aggregates. Fibrilization
was carried out under the same conditions as described
for mOligomers with the incubation time extended
overnight. Insoluble fibrils were washed thoroughly to
remove any remaining monomer and mOligomer. Fibrils
were resuspended in 300–400 μl of PBS + 0.01 % azide
and sonicated for 20 s at 60% power. The sonicated
sample was ultracentrifuged, purified and concentrated as
described above. These oligomers, which were recovered
from fibril fragmentation, are termed fOligomers.
Both types of oligomer were stored at 4°C and
used within 24 h for structural and electrophysiological
investigations.
Dot blot analysis
Blotted aliquots of αSyn (10 × 2 μl) were dried on
nitrocellulose before being blocked for 1 h in Tris-buffered
saline (TBS: 10mMTris; 150mMNaCl; pH7.5)+Tween20
(TBST) containing 2% dried skimmedmilk (Marvel; Pre-
mier Foods, St Albans, UK). Primary antibodies were
diluted 1:1000 and secondary antibodies were diluted
1:5000 in the blocking buffer. Mouse anti-αSyn antibody
(catalogue number 610786; BD Biosciences, Clontech,
Palo Alto, CA, USA) was used to detect the presence of
αSyn regardless of structure, the secondary for which
was anti-mouse IgG conjugated to alkaline phosphatase
(Apase; Promega, Madison, WI, USA). Rabbit polyclonal
A11 antibody (catalogue number AHB0052; Invitrogen,
Carlsbad, CA, USA) was used to specifically detect
oligomeric αSyn (Kayed et al. 2003), the secondary for
whichwas anti-rabbit IgGconjugated toAPase (Promega).
Before and after the addition of secondary antibodies,
the paper was washed thoroughly in TBST to remove
non-specific binding. A final wash in TBS was carried
out to remove Tween20 prior to the addition of Western
Blue (Promega), a substrate for APase, that enabled
visualization of the target protein.
Circular dichroism (CD) and fluorescence spectroscopy
Far-UV CD spectra (190–260 nm) were measured with a
J-815 spectropolarimeter (Jasco, Chelmsford, UK) using
1 mm path length quartz cuvettes, a scanning speed of
100 nm min−1, a time constant of 1 s and bandwidth of
1 nm. Spectra were collected at a resolution of 0.5 nm
and an accumulation of 16–32 scans were averaged per
spectrum. CD spectra were analysed using DichroWeb
(Whitmore & Wallace, 2004, 2008), comparing spectra
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with a reference data set (Set 7) using the SELCON3
analysis algorithm (Sreerama &Woody, 1993).
Fluorescence spectra were recorded with a
spectrofluorometer (Photon Technology International,
Stanmore, UK) using a 4 mm path length quartz cuvette.
The sample was excited at 295 nm (2 nm bandwidth) and
the emission spectra were recorded from 300 to 450 nm
(2 nm bandwidth) with a resolution of 1 nm and an
integration time of 1 s. Each spectrum was the average of
four scans.
Analytical ultracentrifugation (AUC)
Protein samples were prepared <24 h in advance and
analysed using a ProteomeLab XL-I (Beckman Coulter,
Fullerton, CA, USA) protein characterization system.
Samples were diluted in PBS to give a final concentration
of 0.1–0.2 mg ml−1 as determined by a single scan
(A280) at 3000 rpm. The sedimentation coefficient was
determined from a total of 285 scans per sample. AUCwas
carried out at 20± 0.1°C in sedimentation velocity mode.
The heterogeneity of oligomer samples was assessed by
comparing the peak width at half-height.
Transmission electron microscopy (TEM)
Copper electronmicroscopy grids, 400mesh with formvar
carbon support film (Agar Scientific, Stansted, UK), were
hydrophilized in a K100x Glow Discharger (Quorum
Technologies, Lewes, UK). Protein samples were adsorbed
over 60 s, stained using 2% uranyl acetate and then
washed with distilled water. Images were collected on
a JEM2011 CyroTransmission electron microscope (Jeol
Inc., Peabody, MA, USA) with 200 kV acceleration,
and analysed semi-automatically using ImageJ software
(NIH, Bethesda, MD, USA). To define oligomer structure,
measurements were made from at least three pre-
parations of each oligomer species, with multiple electro-
nmicroscopy images captured from each preparation.
Over 20 TEM images were analysed for each oligomer
with50 particles analysed per image.
Preparation of neocortical slices
All experiments were approved by the Animal Welfare
and Ethical Review Body (AWERB) at the University of
Warwick. In accordance with the UK Animals (Scientific
Procedures) Act (1986), male B6CBF1 mice (postnatal
days, P28–35) were killed by cervical dislocation and
decapitated. The brain was rapidly removed and cut down
themidline. Parasagittal neocortical brain slices (300μm)
were cut at an angle of +15° such that the blade cut from
the surface of the neocortex towards the caudal border of
the neocortex (ensuring the integrity of layer V pyramidal
cell dendrites) using a Microm HM 650 V microslicer
(ThermoScientific). Sliceswere preparedusing an ice-cold
cutting solution (in mM: 127 NaCl, 1.9 KCl, 8 MgCl2,
0.5 CaCl2, 1.2 KH2PO4, 26 NaHCO3 and 1 D-glucose).
Slices were transferred to a Gibbs chamber containing
standard artificial cerebrospinal fluid (inmM: 1MgCl2 and
2 CaCl2) bubbled with 95%O2/5%CO2, and incubated at
34°C for 60min and then at room temperature (20–22°C)
until use.
Whole-cell patch clamp recordings from pyramidal
cells
A slice was transferred to the recording chamber, sub-
merged in artificial cerebrospinal fluid and perfused
at a constant flow rate of 3 ml min−1 (32°C). Slices
were visualized using an BX51W1 microscope (Olympus,
Tokyo, Japan) with IR-DIC optics and a KP-M1A
CCD camera (Hitachi, Tokyo, Japan). Single or paired
whole-cell patch clamp recordings were made from
pyramidal neurons using patch pipettes (4–8 M
resistance) manufactured from thick walled borosilicate
glass (Harvard Apparatus, Edenbridge, UK) containing
(in mM): 135 potassium gluconate, 7 NaCl, 10 Hepes,
0.5 EGTA, 2 ATP, 0.3 GTP, 10 phosphocreatine and 0.05
Alexa Fluor 488 hydrazide, 300 mosm (pH 7.2). Various
αSyn species were added to the intracellular recording
solution prior to patch clamp recording to give a final
concentration of 0.5 μM (5 % v/v). In control cells, the
vehicle PBS (5 % v/v) was added to the intracellular
solution.
The voltage responses from current clamped neurons
were recorded using a Multiclamp 700B amplifier
(Molecular Devices, Sunnyvale, CA, USA) and digitized at
20 kHz using a Digidata 1440a (Molecular Devices). Data
was acquired using pCLAMP software (Clampex, version
10; Molecular Devices). The liquid junction potential
(calculated as 13 mV) was uncompensated. TTL5
pyramidal cells were identified based on their location in
the layered neocortex, somata size and dendritic extent.
During the recording, neurons were labelled with the
fluorescent dye Alexa Fluor 488 to enable confirmation
of the cell type and to ensure an intact apical dendrite.
Immunostaining and confocal imaging
After patch clamp recording, brain sliceswere immediately
fixed in 4 % paraformaldehyde for at least 1 h at 4°C,
after which the slice was washed repeatedly with PBS.
Slices were incubated for 1 h at room temperature
in blocking buffer (1 % BSA, 0.4 % Triton X-100 in
PBS) before being suspended in either anti-αSyn or
A11 antibodies (for details, see section on Dot blot
analysis), 1:100 dilution in blocking buffer, for 1 h at
room temperature followed by overnight incubation at
4°C. The primary antibodies were aspirated and the
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slices washed thoroughly in PBS (5 × 10 min) prior to
the addition of secondary antibodies (1:100 in blocking
buffer): Alexa Fluor 568 goat anti-mouse IgG (H+L) for
anti-αSyn staining or Alexa Fluor 647 chicken anti-rabbit
IgG (H+L) for A11 staining (#A11004 and #A21443,
respectively;Molecular Probes, Carlsbad, CA,USA). Slices
were incubated for 4 h at room temperature andwashed in
PBS afterwards. Slices were also stained with the nuclear
stain 4′,6-diamidino-2-phenylindole (DAPI) (1 μg ml−1
in blocking buffer). Slices were mounted on Polylysine
adhesion slides (Thermo Scientific) and preserved in
Vectashield medium (Vector Laboratories, Burlingame,
CA, USA). Slices were stored at 4°C before imaging
with confocal microscopy (TCS SP5; Leica Microsystems,
Wetzlar, Germany).
Fluorescence conjugation
For a subset of neurons, αSyn-Dylight 594 conjugated
monomer was added to the intracellular solution. A
sample of αSyn monomer was tagged using a Dylight
labelling kit (Thermo Scientific) in accordance with the
mnufacturer’s instructions. In brief, monomeric αSyn
stock was diluted to 1 mg ml−1 in PBS + 0.05 M borate
buffer and added to 65μg of lyophilized Dylight 594 NHS
ester. The mixture was protected from light and left to
stand for 4 h at room temperature. Unbound ester was
removed using the purification resin and microcentrifuge
spin columns provided.Monomeric αSyn was found to be
labelled at a ratio of 2.57mol dye (mol protein)–1. Labelled
αSyn was aliquoted, flash frozen and stored at −20°C
until use.
Stimulation protocols
To extract the electrophysiological properties of recorded
neurons, both step and more naturalistic, fluctuating
currents were injected at 8 min intervals (start-to-start)
for a total duration of 32 min.
Standard I–V protocol
The standard I–V relationship was obtained by the
injection of step currents; starting between −600 to
−400 pA, and incrementing by 100–200 pA until a
regular firing pattern (6–12 Hz) was induced. A plot of
step current against average voltage response around the
resting potential was used to measure the input resistance
(gradient of fitted line).
Dynamic I–V protocol
The dynamic I–V curve was generated from the neuro-
nal response to a continuously injected waveform (noisy
current), which reflects ongoing synaptic activity. The
dynamic I–V curve, definedby the average transmembrane
current as a function of voltage, can be used to efficiently
parameterize neurons and generate reduced neuron
models that accurately mimic the cellular response. The
complete method has been described previously (Badel
et al. 2008); for the dynamic I–V computer code, see also
Harrison et al. (2015). A brief account is given below.
Injected noisy current traces were constructed from the
summed numerical output of two Ornstein–Uhlenbeck
processes (Uhlenbeck & Ornstein, 1930) with time
constants τfast = 3 ms and τslow = 10 ms. These stochastic
waveforms mimic the background post-synaptic activity
resulting from activation of AMPA and GABAA receptor
channels. Two sets of variances were applied to the wave-
form (low; σfast = σslow = 0.18 and high; σfast = 0.36,
σslow = 0.25), both with a DC bias of 0.06 (relative
units), to give two different current traces (LowV-06 and
HighV-06). Each trace had a duration of 40 s and was pre-
ceded and followed by 5 s of zero current (null stimulus).
The traces were multiplied by a gain factor (300–800 pA)
when injected to give a desired firing rate of 5–15 Hz.
In a small number of experiments, the gain factor was
kept constant at 400 pA throughout the time course to
investigate the effects of αSyn on firing rate. For each
time point, both the low and high variance traces were
injected in series and then averaged to give the neuronal
parameters.
The dynamic transmembrane current (Iion) can be
calculated as:
Iion(V, t) + Inoise = Iinj(t) − CdV
dt
(1)
for which the injected current (Iinj) is known beforehand,
the derivative (dV/dt) can be calculated from the
experimentally measured voltage and the capacitance (C)
is attained from a minimum variance procedure (Badel
et al. 2008). A scatter plot of the transmembrane
current against voltage illustrates the dynamic relationship
between the two, with the effects of weak background
synaptic activity and other sources of high-frequency
variability being accounted for as intrinsic noise (Inoise)
(Badel et al. 2008). Averaging the transmembrane current
in 1 mV bins removes the time dependence of Iion (V,t)
to yield the typical ionic current and a particular voltage,
and so defines the dynamic I–V curve (Idyn).
Idyn(V) = Mean [Iion (V, t)] (2)
Following earlier studies (Badel et al. 2008;
Harrison et al. 2015), we found that the exponential
integrate-and-fire model (Fourcaud-Trocme et al. 2003)
provided an excellent fit to the dynamic I–V curve.
The exponential integrate-and-fire (EIF) model is
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characterized by a voltage forcing term F(V) that is related
to the Idyn as:
F (V) = −Idyn (V)
C
(3)
where the steady-state forcing function F(V) for the EIF
model is given as:
F (V) = 1
τ
(
E − V + Texp
(
V − VT
T
))
= − Idyn(V)
C
(4)
The EIF model has four parameters: membrane
time constant (τ), resting potential (E), spike-initiation
threshold (VT) and spike-onset sharpness (T), which
describes the voltage range over which an action potential
initiates.
Pre-spike parameters were calculated using a dynamic
I–V curve fitted to the EIF model. Dynamic I–V
curves were constructed solely from the pre-spike voltage
response (subthreshold and run up to spike) with all data
falling within a 200 ms window after each spike being
excluded from analysis.
Percentage spike match
Parameters were fed into the EIF model to simulate a
voltage response to the same noisy current inputs. The
accuracy of these parameterswas then tested by comparing
the simulated response with the experimentally recorded
voltage trace. The number of matching spikes, aligning to
within ± 5 ms, was typically 60–90%.
Statistical analysis
Using either the standard or dynamic I–V methods,
parameters were extracted from neurons with different
treatments of αSyn and over a range of time points.
Individual treatmentswere compared across different time
points using repeated measures ANOVA. At set time
points, different αSyn treatments were analysed using
two-tailed t tests with Bonferoni correction for multiple
comparisons. All neuronal parameters are presented as the
mean with either the SD or SEM.
Results
Characterization of αSyn oligomers
For the production of αSyn oligomers, we used
recombinant αSyn with two point mutations: E46K
(a mutation found in familial PD that accelerates
aggregation) (Choi et al. 2004) and Y39W to enable
fluorescence spectroscopy. The latter was introduced
because αSyn does not have any native tryptophan
(Trp) residues and has been shown not to affect either
αSyn secondary structure (Dusa et al. 2006) or the
kinetics of fibril formation (van Rooijen et al. 2009). To
induce oligomerization, monomeric αSyn was incubated
at 37°C with agitation. Dot blots, with the oligomer
specific antibody (A11), were taken periodically to assay
the formation of oligomers (Fig. 1A). Oligomers were
detectable as early as 30min of incubation but consistently
showed the strongest immunoreactivity after 2–3 h,
during which αSyn had formed a mixture of early
stage aggregates including protofibrils (Fig. 1Ba). With
longer incubations, immunoreactivity to the A11 anti-
bodywas lost and late stage aggregates, especially insoluble
fibrils, were the major forms of αSyn present (Fig. 1Bb).
The A11-positive samples, after 2–3 h of incubation,
were ultracentrifuged and the supernatant loaded onto
size-exclusion chromatography to separate oligomers
frommonomers. The resulting purified soluble oligomers
were termed mOligomers because they were derived
directly from monomers. In addition, insoluble fibrils
(produced from overnight incubation) were fragmented
by a short burst of probe sonication, which subsequently
recovered a separate population of soluble oligomers,
termed fOligomers. BothmOligomers and fOligomers were
positive for A11 immunoreactivity and exhibited a distinct
ring-like structure under TEM (Fig. 1Bc and Bd). Both
populations had similar size diameter (mean ± SD:
mOligomer 14 ± 3 nm; fOligomer 14 ± 3 nm) and central
cavity (mOligomer 4 ± 1 nm; fOligomer 4 ± 1 nm).
AUC of αSyn monomer (Fig. 1Ca), mOligomers and
fOligomers (Fig. 1Cb) produced peak sedimentation
coefficients of 1.2 S, 11.6 S and 11.3 S, respectively. Mass
transformation of these peaks gave a predicted molecular
mass of 8 kDa formonomer and between 250 and 260 kDa
for both oligomer species, suggesting that the oligomers
are composed of 30 monomers. The peak width at
half-height was 0.3 S for monomer, 5.4 S for mOligomer
and 5.0 S for fOligomer. It is worth noting that the native
αSyn tetramer (Bartels et al. 2011) would be expected to
give a peak at 5 S, which is observed in the mOligomer
sample but not the fOligomer, presumably because the
sonication split the tetramers apart.
Fluorescence spectroscopy was used to measure the
emission spectrum of Trp39 during αSyn aggregation
(Fig. 1D). The emission wavelength of Trp fluorescence
is dependent on its exposure to the environment. Trp
residues that are buried within proteins display a blue
shift compared to solvent-exposed Trp residues. Being
structurally unfolded, monomeric αSyn has a freely
exposed Trp39 with a fluorescence peak of 350. Upon
oligomerization, the external tryptophan becomes buried
resulting in a blue shift of the emission peak to 335. Inter-
estingly, the blue-shifted peaks for purified fibrils and
fOligomers were 339 and 341 nm, respectively. They are
still notably shifted from the monomer but significantly
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 1. Formation of αSyn oligomers and their structural characterization
A, dot blots probed with A11 antibody are used tomonitor the aggregation of monomeric αSyn over time (negative
control: BSA). Ba, TEM imaging at an A11-positive time point (3 h) reveals a mixture of early-stage aggregates
comprising monomers, oligomers and protofibrils. Bb, if aggregation is allowed to continue for longer (over 4 h),
A11 immunoreactivity is lost and large fibrils are formed. Bc, the supernatant from ultracentrifuged early-stage
aggregates provides a sample of soluble, ring-like oligomers, termed mOligomers. Bd, sonication of late-stage
fibrils also recovers soluble, ring-like oligomers (fOligomers) (TEM scale bars = 100 nm; insets = 25 nm). Ca and
Cb, the size and sample heterogeneity of monomer and both oligomers was determined by ATC. D, the degree of
blue shift exhibited by Trp39 in αSyn monomer, oligomers and fibrils, determined by fluorescence spectroscopy,
provides information about the local structure. Ea, the secondary structure of αSyn populations was analysed with
CD spectroscopy. Eb, the percentage structure was determined using DichroWeb. In all plots: αSyn monomers
(green), mOligomers (red), fOligomers (yellow) and fibrils (grey).
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less than that of themOligomer (Fig. 1D, inset) suggesting
that fibril fragmentation might recover oligomers with an
altered structure.
The secondary structure of the αSyn species was
measured using CD spectroscopy (Fig. 1Ea) and analysed
using DichroWeb (Fig. 1Eb). Monomeric αSyn showed
a typically unfolded protein structure, with a prominent
negative band at <200 nm, whereas fibrillar αSyn had a
218 nmminimum characteristic of β sheet. The spectrum
for mOligomer differs from fibrils because the minima is
shifted to 212 and the 190 peak is more strongly positive.
Similar tomOligomers, the spectrum for fOligomer clearly
diverges from fibrils in wavelength intensity, particularly
between 190–210 nm. However, the consistent minimum
at 218 suggests the presence of β sheet rather than α helical
structure. Importantly, neithermOligomer, nor fOligomer
spectra could be reconstructed from linear combinations
of the monomer and fibril spectra (differences were
especially prominent between 200 and210nm), indicating
that both oligomers exist as their own distinct species.
Overall, these data suggests that, although the two oligo-
mer species have similar morphologies (annular structure
with approximately the same number of subunits),
they display secondary structure characteristics that are
different from one another; mOligomers are predomi-
nantly α helical, whereas fOligomers have more β sheet.
αSyn oligomers and monomers were introduced into
pyramidal cells
To investigate the effects of αSyn species on neuronal
electrophysiology, oligomeric and monomeric αSyn were
introduced into TTL5 pyramidal cells via the patch pipette
duringwhole-cell patch clamp recording. TTL5 pyramidal
cells (Fig. 2A) were chosen because their electro-
physiological properties are well characterized (Markram,
1997), the dynamic I–Vhas previously beenused to extract
their electrophysiological parameters (Badel et al. 2008;
Harrison et al. 2015) and they are affected in late stage PD
(Braak et al. 2003; Poewe, 2008). In initial experiments, we
confirmed that oligomeric αSyn preparations remained
immunoreactive to the oligomer-specific antibody (A11)
once they had been dissolved in intracellular solution and
passagedoutof the tipof patchpipettes (Fig. 2B).However,
filtering (filter pore size 0.45 μm) of the intracellular
solution, aiming to prevent any clogging of the recording
pipette, removed A11 immunoreactivity. Thus, the intra-
cellular solution was only filtered before the addition of
αSyn oligomers. We also confirmed that both oligomers
and monomers could be detected inside TTL5 pyramidal
cells following whole-cell patch clamp recording. This
was achieved using either the A11 antibody (Fig. 2Ca)
or an αSyn protein specific antibody because little end-
ogenous αSyn is expressed in the cell bodies of TTL5
pyramidal cells (Fig. 2Cb). As an alternative method,
Dylight594-conjugated αSyn monomer was also injected
intoneurons to further demonstrate that theprotein is able
to diffuse out of the patch pipette into the cell (Fig. 2Cc).
This allowed us to observe the monomer moving into
cells in real time with diffusion of fluorescence into the
soma and apical dendrite observed within a few minutes
of whole-cell breakthrough (Fig. 2E).
Including αSyn in the patch pipette could potentially
lead to an increase in the series resistanceduring recording,
compromising recording quality, particularly if the tip of
the electrode becomes blocked by αSyn aggregates. Thus,
we carefully monitored series resistance during recordings
and rejected any recordings in which the series resistance
exceeded 15.0 M (Fig. 2D). In the data set (18 control
vehicle recordings, 20 with monomer, 19 withmOligomer
and 13 with fOligomer), there was no significant difference
in the series resistance at time zero (mean ± SEM break-
through into the whole cell: control 12.2 ± 0.28 M,
monomer 12.1± 0.18 M,mOligomer 11.81± 0.20 M,
fOligomer 12.0 ± 0.18 M) and after 32 min of recording
(control 13.1 ± 0.23 M, monomer 12.6 ± 0.19 M,
mOligomer 12.38± 0.19M, fOligomer 12.3± 0.14M).
To generate a time course for changes in electro-
physiological parameters, neurons were periodically
stimulated with both standard step currents (Fig. 3A)
and noisy currents (Fig. 3B) injected in series at 8 min
(start-to-start) intervals, over a total period of 32 min,
and the subsequent voltage responses were recorded.
The standard I–V curve was generated from the sub-
threshold response to step-current stimuli either before
(Vsag) or after (Vsteady) the effects of IH (Fig. 3C). The
dynamic I–V curve (Idyn) is equivalent to the average ionic
current (Fig. 3D), calculated from the difference between
injected current (Iinj) and capacitive current (CdV/dt), at a
given voltage during naturalistic activity (Fig. 3E; see also
Methods) (Badel et al. 2008). The forcing function for an
exponential EIF model equates to the inverse of Idyn over
capacitance, as shown by eqn (3), thus providing a rapid
and accurate protocol for extracting neuronal parameters
(Fig. 3F).
Parameter fittings generate reduced neuron models
that accurately fit experimental voltage traces
To assess the quality of parameters extracted from the
dynamic I–Vmethod, the experimentally recorded voltage
responses were compared with simulations using the
EIF model with the extracted parameters (Harrison
et al. 2015). The percentage of matching spikes between
recorded and simulated traces (±5 ms) was >70% for
control, monomer and either of the oligomeric species
and did not significantly differ for each of the injected
species (after 32min, the percentage of correctly identified
spikes was: control 79.1 ± 2.9 %, monomer 77.0 ± 3.6 %,
mOligomer 72.4 ± 3.7 % and fOligomer 75.7 ± 5.5 %)
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 2. The intracellular injection of αSyn monomer and oligomers into thick-tufted layer 5 (TTL5)
pyramial neurons
A, TTL5 neurons were identified by their distinct morphology and depth in the neocortex (green, Af488 dye, which
is added to enable visualization; blue is the DAPI nuclear stain). B, dot blots showing that oligomeric αSyn stays
A11-positive when dissolved in intracellular solution and when subsequently passed out of the tip of a patch
pipette. However, oligomer-containing intracellular did not remain A11-positive after being filtered indicating
that the oligomers did not pass through the filter. Ca, during whole-cell patch clamp recordings, oligomeric
αSyn diffused into the recorded neuron and was detected by immunofluorescence staining (red is A11, yellow
in overlay). Cb, paired whole-cell recordings from TTL5 neurons, with αSyn monomer injected in the top neuron
and vehicle (PBS) injected in the bottom neuron. The top neuron is stained with anti-αSyn antibody (red, yellow
in overlay), whereas the bottom neuron is unstained (green in overlay), reflecting the low level of endogenous
αSyn in the soma of TTL5 neurons. Cc, injecting conjugated αSyn–Dylight594 demonstrated αSyn diffusion into
the recorded neuron. D, series resistance (measured from the bridge balance, mean ± SEM) against time for cells
injected with vehicle (control), monomer and both types of oligomer. Series resistance did not significantly change
during recordings and did not differ depending on treatment. E, time lapse pictures illustrating the rapid diffusion
of conjugated αSyn–Dylight594 out of the patch pipette into the recorded cell. Scale bars = 50 μm.
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(Fig. 4). This degree of spike matching is similar to pre-
viously reported values for TTL5 pyramidal cells (Badel
et al. 2008; Harrison et al. 2015). Thus, the accuracy of
parameter extraction is not compromised by dialysis of
neurons with either monomeric or oligomeric αSyn. Note
that the spike matching will never be 100 % as a result of
spontaneous synaptic activity in experimental recordings
that is absent in the simulations.
αSyn oligomer infusion changes neuronal properties
αSyn monomers and oligomers were infused into TTL5
pyramidal cells via the patch pipette (all at 0.5 μM). In
control recordings, an equivalent volume of the vehicle
in which the monomer and oligomers were dissolved
(PBS 5% v/v) was added to the intracellular solution.
Dynamic I–V curves were generated for each treatment
and at each time point (Fig. 5A). A number of neuro-
nal parameters were extracted from the subthreshold and
pre-spike data: membrane capacitance (C), membrane
time constant (τ), input resistance (Rin = τ/C), resting
membrane potential (E), spike threshold (VT) and spike
onset sharpness (T) (Fig. 5B). Themean action potential
amplitude (Aamp), duration (Adur) andmaximal rate of rise
(Arise) were taken directly from the voltage response to
noisy currents and calculated as described in Sekerli et al.
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C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
J Physiol 000.0 Impact of α synuclein on neocortical neurons 11
(2004).Additional firingparameters, comprisingpotential
between rest and threshold (VT – E) and spike-initiation
current Ispike = (VT – E)/Rin, were extracted to give a
measure of neuronal excitability.
In neurons infused with vehicle (control, n = 18), the
subthreshold parameters remained stable for the duration
of experiments, values were not significantly different
when measured at 8 min compared to those measured
at 32 min following whole-cell breakthrough (P > 0.05
for all parameters) (Table 1). These parameter values are
similar to those reported previously for mouse TTL5
neurons (Dani & Nelson, 2009; Oswald et al. 2013).
Because the parameters in control neurons were stable for
at least 32 min, we first investigated whether parameters
significantly changedat this timepoint forneurons infused
with αSyn species, thus giving time for the injected
species to diffuse out of the patch pipette and have an
effect. Injection of αSyn monomer (n = 20) produced no
significant change (P > 0.05) in any of the parameters
compared to control (Fig. 5B and Table 1). However, there
were significant changes in some of the parameters for
both mOligomer (n = 19) and fOligomer (n = 13) filled
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Figure 4. The dynamic I–V (DIV) method allows accurate electrophysiological parameter extraction
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neurons.Therewas a significant (P<0.005)decrease in the
input resistance (Rin) of recorded cells: from (mean± SD)
89.0 ± 22.3 M in control cells to 55.1 ± 16.0 M and
59.7 ± 18.6 M in cells infused with mOligomers and
fOligomers, respectively, which is an average reduction
of 40 % (Fig. 5B and Table 1). The membrane time
constant was also significantly reduced (P < 0.005) from
16.1± 4.6 ms (control) to 11.8± 2.9 ms (mOligomer) and
13.1 ± 3.3 ms (fOligomer), which is an average reduction
of 35 %. The membrane capacitance was significantly
increased by an average of 20 % in oligomer infused
cells: from 183 ± 39.8 pF (control) to 219 ± 40.3 pF
(mOligomer, P < 0.005) and to 228 ± 56.1 pF (fOligomer,
P < 0.05).
To investigate the time course for these changes in input
resistance, membrane time constant and capacitance, we
examined the parameters at earlier time points (8, 16
and 24 min). For each time point, the parameters for
oligomer infused neurons remained significantly different
from those from control neurons (Fig. 5B and Table 1).
This suggests that the effects of the oligomers on these
parameters occurred rapidly, within the first few minutes,
and then stabilized for the duration of the recordings.
Interestingly, there was no significant difference between
the effects of mOligomers and fOligomers on input
resistance, membrane time constant or capacitance at the
different time points (P > 0.05).
The resting membrane potential and spike onset
sharpness were unaffected by αSyn species at any of the
time points (Fig. 5B and Table 1). The spike-threshold
voltage, however, was significantly reduced in mOligomer
filled neurons (mean ± SD, 32 min, −56.0 ± 3.6 mV)
compared to control (−52.6± 5.4 mV, P= 0.003) but not
in fOligomer filled neurons (−52.7 ± 1.8 mV, P = 0.841).
The effects of mOligomers and fOligomers on sub-
threshold parameters are illustrated by their effects on
the average dynamic I–V curves (Fig. 5A). The change in
membrane time constant, for example, is seen as a steeper
gradient for the linear portion of the dynamic I–V curve.
Similarly, the change in the threshold VT is conveyed by
the leftward shift of the mOligomer curve that is not seen
for the fOligomer curve (Fig. 5A). Although no significant
change in restingmembrane potential was found for either
oligomer, their curves intersect with the control curve at
around −80 mV, suggesting that αSyn oligomer-induced
conductance has a reversal potential close to this
voltage.
The reduction in input resistance is confirmed
by changes in response to step currents
Tocorroborate thefindings fromthedynamic I–Vmethod,
the input resistance was also measured from the gradient,
around rest, of the standard I–V curve either before or after
the effects of the sag as a result of IH activation (Fig. 6A).
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After 32 min, the input resistance was (mean ± SEM)
69.1± 3.8 M in the control compared to 45.4± 1.8 M
in mOligomer and 45.8 ± 3.4 M in fOligomer. Thus,
a reduction in input resistance similar to that measured
by the dynamic I–V was observed (35% reduction;
P < 0.005) (Fig. 6B).
It would be predicted that the input resistance of
neurons infused with either vehicle or oligomer should
be the same just after breakthrough into the whole cell
because there has not been sufficient time for the oligomer
to diffuse into the cell. Because the standard I–V curve
can be generated from a much shorter stimulus than
the dynamic I–V, this method was used to measure the
input resistance at time zero. As shown in Fig. 6D, the
input resistance was not significantly different between
cells injected with vehicle (control, 52.1± 6.3 M, n= 6)
and mOligomer (49.6 ± 5.4 M, n = 6) at time zero
(P = 0.78) but became significantly different after 16 min
(VSteady: control Rin 58.7 ± 3.2 M vs. mOligomer Rin
44.2 ± 2.6 M, P = 0.001) (Fig. 6C), confirming that the
changes in input resistance occur within a short period
after breaking through into the whole cell.
In a subset of cells, the concentration of mOligomer
in the intracellular solution was increased from 0.5 to
1.5 μM (n = 4) to determine whether the effects on
parameters were concentration-dependent. A fall in input
resistance was still observed for mOligomer at this higher
concentration (not shown); however, the change was
not significantly greater than that observed with a lower
concentration. Increasing the monomer concentration
from 0.5 to 1.5μM (n= 7) still did not lead to a significant
change in input resistance.
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Figure 6. The αSyn oligomer-induced fall in input resistance is also observed in standard I–V curves
constructed from step currents
A, standard step I–V curves generated from the maximum voltage response before the sag (open) and during
the steady-state (filled) after 32 min of recording. The shallower gradient at 0 mV for the mOligomer I–V
curve (squares) compared to control (circles) illustrates a reduction in input resistance. Inset: voltage responses of
neurons filled with either vehicle (control) ormOligomer (step currents were –400 and 100 pA). B, summary of input
resistance measured at 32 min for control, monomer, mOligomer and fOligomer (the filled circles are the mean
values). C, step currents were used to measure the input resistance immediately after whole-cell breakthrough.
At this early time point, the input resistance was the same for control and mOligomer but became significantly
different over time (input resistance was measured at steady-state). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.005.
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Oligomeric αSyn reduces neuronal excitability
With a reduction in input resistance, the voltage response
to a given current will decrease. Thus, it would be expected
that a larger current (Ispike) would be required to reach
the action potential firing threshold. For neurons infused
with either oligomeric species, there was a more than
60 % increase in Ispike amplitude compared to control
(P < 0.005) (Fig. 7A). However, the potential difference
between the resting voltage and threshold (VT – E) was not
significantly affected by αSyn treatments (Fig. 7B).
It would be predicted that the firing rate of oligomer
infused cells would be lower than cells injected with
vehicle, for a given current input. In most recordings,
this could not be directly observed because the gain factor
for the injected noisy currents was altered to maintain the
same firing rate (i.e. a consistent firing rate is required for
accurate parameter measurement; see Methods) (Badel
et al. 2008). It was noted, however, that a higher gain
factor was often required for oligomer filled cells than
for cells injected with vehicle to produce the same firing
rate. In a subset of recordings, the gain of the current
input was set at the same level (400 pA) for both control
cells and interleaved oligomer infused cells to allow the
firing rate to be directly compared (Fig. 7C and D). After
32 min, the mean ± SEM firing rate was 9.4 ± 0.54 Hz
(n= 5) in control neurons compared to only 5.6± 1.14Hz
in mOligomer filled neurons (n = 5), which is a marked
(P < 0.005) decrease in firing rate (on average, a decrease
of40%) (Fig. 7D). To investigate this further, simplified
neuronmodels fitted to the experimental parameters were
simulatedwith increasing input current gain factors (from
400 to 1000 pA in steps of 100) (Fig. 8). This linear
increase in firing rate was significantly reduced (as
determined by analysis of covariance) in simulations using
parameters fromeither fOligomer (P< 0.05) ormOligomer
(P < 0.005) filled neurons compared to either control
or monomer (Fig. 8). Interestingly, the simulated firing
rate for mOligomer was reduced after 8 min, whereas
fOligomer only had a significant effect after 32 min.
This later reduction was also significantly weaker than
produced by mOligomers (the gradients of the linear
regressions were significantly different from one another;
P < 0.005).
Oligomeric αSyn reduces action potential duration
We investigated whether αSyn oligomers had any effect on
the action potential bymeasuring a number of parameters
that define the action potential waveform (Fig. 9A).
There was no significant difference in action potential
amplitude. However, action potential duration (Adur)
was significantly reduced by both mOligomer (8 min;
P < 0.005) and fOligomer (P < 0.005) but not by mono-
mer (P = 0.606) (Fig. 9B). This decrease in duration was
not associated with an increase in the maximal rate of rise
(Arise) of the action potential but, instead, was associated
with a faster rate of repolarization.
Discussion
The present study aimed to combine the structural
characterization of αSyn oligomeric species with
detailed insight into their time-dependent effects on
electrophysiological parameters measured in neocortical
neurons. We generated two distinct species of oligomer
with similar morphologies but different secondary
structures. We then took the unique approach of
introducing these oligomeric species directly into neurons
during whole-cell patch clamp recording. This approach
has major advantages: it only requires a small amount of
oligomeric species compared to extracellular incubation
and it allows changes in neuronal parameters to be
measured in real time. Because the recorded neurons
are healthy before recording and the introduction of
oligomers, changes in neuronal properties can be observed
in real time unlike with extracellular pre-incubation. In
the majority of experiments, we used a concentration
of 0.5 μM in the pipette solution for both αSyn
monomers and oligomers. We based this on previous
studies showing extracellular effects of αSyn oligomers
within a concentration range of 0.1–0.5 μM (Diogenes
et al. 2012; Martin et al. 2011; Tosatto et al. 2012).
The precise concentration of αSyn oligomers inside
neurons in pathological states is unclear, although it
will almost certainly be higher than in the extracellular
space.
Soluble αSyn oligomers isolated during
the aggregation process or recovered from fibril
fragmentation have similar morphologies but differ
in secondary structure
Two populations of αSyn oligomer were isolated from
different stages of the aggregation process. Oligomers that
were formed directly from monomer under fibrillizing
conditions, mOligomers, were produced in accordance
with a protocol used previously to give structural and
kinetic information (Lorenzen et al. 2014). This soluble
mOligomer species has a ring-like shape (annular), is
14 nm in diameter with a central cavity of 4 nm
and is comprised of 30 monomer subunits, which are
properties similar to those reported previously (Lashuel
et al. 2002).
We also found that soluble, A11-positive, oligomers
could be recovered after subjecting fully formed fibrils to
sonication, fOligomers. These oligomers had a very similar
morphology tomOligomers but differed in their secondary
structure (discussed below). Fibril fragmentation is a
key determinant of the physiological impact of amyloid
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 7. Neurons infused with αSyn oligomers show a marked reduction in excitability
A, scatterplots of spike initiation current (ISpike), the amount of current required for a resting neuron to reach
threshold, at different time points from whole-cell breakthrough for control; monomer and oligomer-infused cells.
B, scatterplots of the voltage difference between resting and threshold (VT – E) from whole-cell breakthrough for
control; monomer and oligomer-infused cells. A and B, open circles are values from individual recordings and the
filled circles are mean values. C, example voltage responses to a noisy current stimulus (gain = 400 pA) for a cell
filled with vehicle (PBS, control) and a cell filled with mOligomer. D, bar chart plotting the mean firing rate for
neurons infused withmOligomer or vehicle against the time from whole-cell breakthrough. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.005.
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proteins (Tanaka et al. 2006; Xue et al. 2010; Wang
et al. 2011b) and may be a more important process
than elongation. For example, amyloid proteins with a
slow growth rate but increased brittleness are more cyto-
toxic than rapidly growing stable amyloids (Xue et al.
2009). It was also observed by Xue et al. (2009) that
fibril fragmentation not only generated new seeds that
rapidly increased the fibril load, but also created a variety
of small fibrilliar species with pathological properties.
The oligomeric population that we recovered from fibril
fragmentation, fOligomers, could represent one of these
pathological species.
The mOligomer CD spectrum (minimum of 212 nm)
suggests that this species has a lower β sheet content
compared to fibrils and is predicted by DichroWeb to
be predominantly α helical in structure. The N-terminal
region of αSyn is capable of forming α helixes and
this appears to be vital for lipid–membrane interactions
(van Rooijen et al. 2009). This region also appears
to be folded in mOligomers because the fluorescence
spectrum from Trp39 is strongly blue shifted, significantly
more so than for fibrils. Thus, the microenvironment
in this region appears altered in the oligomeric state.
The fOligomers, recovered from sonicating fibrils, did not
produce the same level of blue shift or have the same
amount of α helical content as mOligomers, suggesting
that fOligomers retain elements of the fibril structure that
are not present in mOligomers. The distinct structure of
mOligomers points towards them being a species that is
off-pathway fromfibrils; this idea that is supportedby their
ability to inhibit the kinetics of amyloid formation in a
concentration-dependent manner (Timothy J. Kaufmann
and Teresa J. T. Pinheiro, unpublished data; Lorenzen
et al. 2014).
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Figure 8. EIF models predict the reduction in firing rate produced by αSyn oligomers
A–D, firing rate plotted against input current gain factor from EIF models informed by parameters from control,
monomer, mOligomer and fOligomer filled neurons at different time points. The linear regressions at each time
point were subject to analysis of covariance; those marked with an asterisk (∗) had a significantly different intercept
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Figure 9. Action potential duration is reduced in neurons infused with αSyn oligomers
A, the average spike (black) was generated from isolated spikes in voltage responses to naturalistic current with an
interspike-interval greater than 200 ms from a vehicle filled cell (control) and from a cell infused with mOligomer.
The individual spikes are in grey. The spike initiation threshold was calculated using the peak second-derivative
method (Sekerli et al. 2004), shown in dark grey. B, scatterplots of action potential (AP) amplitude, maximum rate
of action potential rise and action potential duration for each time point (8, 16, 24 and 32 min) for all recordings
in the data set. The open circles are values from individual recordings and the filled circles are the mean values.
The duration of the action potential was significantly shorter for oligomer-filled neurons than for either vehicle or
monomer-filled neurons. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.005.
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αSyn oligomers reduce input resistance and increase
cell capacitance
We have taken the novel approach of dissolving αSyn
species into intracellular recording solution and then
injecting them directly into the soma of neurons
during whole-cell patch clamp recording. The intra-
cellular recording solution contains an ATP regenerating
system (phosphocreatine), as well as 2 mM ATP. Such a
system is important because it prevents the ‘rundown’
of many voltage-gated and ligand-gated ion channels
during whole-cell dialysis (Chen et al. 1990; Rosenmund
&Westbrook, 1993). However, it could occlude the effects
of a fall in ATP production as a result of any disruption of
mitochondrial function produced by αSyn species.
After injecting αSyn monomer and oligomeric species
into pyramidal neurons, electrophysiological parameters
were extracted at regular intervals using both standard
and dynamic I–V methods. The dynamic I–V curve
has been shown to reliably and accurately fit reduced
neuron models (Badel et al. 2008). The reliability of
this fit was confirmed by simulating voltage traces with
extracted parameters and comparing them with the
original recorded traces; in all experiments, the percentage
of matching spikes was high and comparable to pre-
vious publications (Fig. 3) (Badel et al. 2008; Harrison
et al. 2015).
Using the dynamic I–Vmethod, we found that neurons
injected with either species of oligomeric αSyn showed
three major changes that occurred rapidly after whole-cell
breakthrough: a marked reduction in input resistance
(Rin), a fall inmembrane time constant (τ) and an increase
in cell capacitance (C). The values for Rin, τ and C for
control (vehicle filled) neurons were similar to those pre-
viously reported for TTL5 pyramidal neurons in mouse
neocortical slices (Dani & Nelson, 2009; Oswald et al.
2013). Although we have no clear measure of the rate of
diffusion of oligomer into neurons, Dylight 594 labelled
monomer could be detected within the soma and dendrite
within a fewminutes. Oligomer is clearlymuch larger than
the monomer and thus will diffuse more slowly. However,
we know that it does diffuse into neurons as a result of
the immunohistochemistry and the observed changes in
neuronal properties and thus must be present within the
soma within 8 min of breakthrough because this is when
we take our first measurement.
It is interesting that the effects of oligomer occur
rapidly, reach a maximum and then there are no further
changes over the duration of the recordings. This is
unexpectedbecause, instead, a slowchange in theneuronal
parameters during the recordings would be predicted as
the oligomer diffuses into the recorded cells and the intra-
cellular concentration increases. One possible explanation
is that, at 0.5μM, the effects of oligomer are at amaximum.
This is supported by the actions of larger concentrations
of oligomer (1.5 μM) that did not have any significantly
greater effect and could be tested further by using lower
concentrations of oligomer to determine whether there is
a slower time course.
The changes produced by oligomeric αSyn, were
not observed with monomer, even if the concentration
of monomer was increased to 1.5 μM. This is inter-
esting because it suggests that, over the time period
of the experiments (up to 2 h for some recordings),
the introduced monomer does not oligomerize inside
the cell. An alternative explanation is that any oligomer
formed inside the cell by monomer is in a different
cellular compartment to the oligomer when it is directly
introduced and thus has different activity.
The oligomer-mediated reduction of Rin will supress
neuronal excitability because the same amount of input
current will produce a smaller voltage change. Thus,
a greater amount of current (ISpike) is required to
reach action potential threshold and the firing rate is
reduced. However, the slow onset for the fall in firing
rate (particularly for the fOligomer) suggests that other
mechanisms may also be involved (see below). The
mechanism underlying the fall in Rin could be the
insertion of channels into the membrane. Increasing
evidence suggests that αSyn oligomers can directly
form pore-complexes that are able to permeabilize lipid
membranes as shown both in vitro (Volles & Lansbury,
2002; Kim et al. 2009; Schmidt et al. 2012) and in cell
culture (Feng et al. 2010; Tosatto et al. 2012; Mironov,
2015). It has also been reported that this pore formation
can be very rapid, occurring within the first 5 min of
incubation (Mironov, 2015). In our experiments, the
oligomer-mediated change in Rin was not present at
time zero (whole-cell breakthrough) but was present after
8–16 min of recording. In common with other studies
(Robinson and Cameron, 2000), we found that the input
resistance in control cells increased during whole-cell
recording and reached a steady-state after 10–15 min,
probably as a result of whole-cell dialysis. This increase
was not observed when cells were infused with oligomer,
suggesting that the effects of oligomer (e.g. pore insertion)
counteracted the effects of cell dialysis. Alternatively,
αSyn oligomers could interact with existing voltage-gated
or ligand-gated ion channels that are already in the
membrane or modify the membrane trafficking of such
channels. For example, it has been reported that there is
cross-talk between αSyn and voltage-gated K+ channels
(Mironov, 2015) and β amyloid oligomers can change
the activity of Kv 1.3 channels, whereas monomers have
no effect (Lioudyno et al. 2012). The recruitment of
voltage-gated K+ channels to the membrane or changes
in K+ channel activation would be consistent with the
observed speeding of action potential repolarization.
Although oligomers produced a marked change in Rin
consistent with an increase in membrane conductance,
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
20 T. J. Kaufmann and others J Physiol 000.0
there was no significant change in themembrane potential
(at 32 min, control −72.3 vs. −74.5 and −73.1 mV, for
mOligomers and fOligomers). One possible explanation is
that the reversal potential for the induced conductance
change is close to the resting potential. It has pre-
viously been reported that the pores formed by αSyn are
non-selective cation channels (Feng et al. 2010; Schmidtt
et al. 2012; Tosatto et al. 2012), which would be expected
to depolarize themembrane potential. By contrast, if αSyn
interacts with K+ channels, the reversal potential for K+
is around −80 mV and close to the resting potential,
which was the point where the dynamic I–V curves inter-
sected (Fig. 5A), and would be expected to produce only a
small hyperpolarization. An alternative explanation is that
inclusion of oligomers in the recording solution changed
the liquid junction potential, which occluded any change
in the resting potential. Although we cannot completely
rule this out, it is not probable because: (1) the amount
of oligomer added to the intracellular solution was very
low; (2) the change in liquid junction potential would
have to be opposite and equal to the change in membrane
potential to occlude it; and (3) there was no change in
the difference between the resting potential (E) and the
threshold potential (VT), which would be altered if the
resting potential had been changed.
The reduction in firing rate developed more slowly
than the rapid change in input resistance (particularly for
fOligomer). This implies that that the change in firing rate
is not solely a consequence of the fall in input resistance
and, instead, may depend on the involvement of other
slower processes; for example, changes in K+ currents or
Na+ channel activation, whichmay be delayed if occurring
in more distal compartments.
Oligomeric αSyn also produced a significant increase
in cell capacitance (20 %). This result would not be
predicted because the build-up of oligomeric aggregates
inside the recordedneuroncouldoccludeneuronalprocess
and thus reduce the effective capacitance of the cell as
measured from the patch electrode. It has been suggested,
however, that amyloid oligomers can insert into lipid
bilayer layers forcing apart the head groups, leading to
a fall in the thickness of the membrane and increasing
capacitance (Sokolov et al. 2006).
The different αSyn oligomers have similar effects
on neuronal properties
Despite their structural differences, the two oligomers
(mOligomers and fOligomers) produced very similar
changes in the electrophysiological properties of TTL5
neurons. Because both oligomeric species have a similar
morphology and are of a similar size, they may also share
the same pathological mechanism. Although there were
differences in their secondary structures, this appeared to
only have subtle effects on their activity. For example, there
appear to be some differences in their effects on the shape
of the dynamic I–V curve and differences on their effects
on neuronal excitability suggesting thatmOligomers had a
greater and faster effect than fOligomers. It has previously
been reported that the membrane permeabilizing activity
of oligomers is dependent on the structural flexibility of
their hydrophobic core (Campioni et al. 2010).Differences
in Trp39 fluorescence and CD spectra indicate potential
differences in core rigidity between mOligomers and
fOligomers that could have an impact on their ability to
interact with membranes.
In conclusion, the electrophysiological impact of
two structurally characterized αSyn oligomers has been
investigated, in detail, for cortical neurons. These two
oligomeric species shared a similar morphology and
produced similar effects on the input resistance and
excitability of neurons. These changes could potentially
affect network activity and thus contribute to the early
changes in cognition observed in PD.
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